文献速递生殖医学

睡眠特征与体外受精/卵胞浆内单精子注射治疗结局的关联:一项前瞻性队列研究

Associations of sleep characteristics with outcomes of IVF/ICSI treatment: a prospective cohort study.
PubMed 文献 · Hum Reprod · 2022-01-01

该前瞻性队列研究纳入1276名接受体外受精/卵胞浆内单精子注射治疗的女性,发现夜间睡眠不足7小时/晚和睡眠紊乱与卵母细胞及胚胎产出受损相关,而较长夜间睡眠可能降低临床妊娠几率,且这种关联受母亲年龄和主观睡眠质量修饰。

要点

  • 与每晚睡7至<8小时者相比,睡<7小时者获卵数和成熟卵母细胞数分别减少11.5%和11.9%。
  • 每周入睡困难超过3次者成熟卵母细胞数、正常受精卵母细胞数和优质胚胎数均降低。
  • 每晚睡9至<10小时者临床妊娠几率低于睡7至<8小时者(比值比=0.65,95%CI:0.44,0.98)。

核心结论

  • 不健康睡眠特征(短夜间睡眠、不适宜睡眠时间、主观睡眠质量差和入睡困难)可能损害卵母细胞数量及其成熟或受精潜能。
  • 长夜间睡眠可能降低不孕女性临床妊娠几率,尤其在30岁以下女性中。
  • 延长夜间睡眠时间可能是改善30岁以上女性和主观睡眠质量差女性体外受精/卵胞浆内单精子注射结局的潜在有益行为,尚需进一步研究。

研究设计与样本

  • 研究基于同济生殖与环境队列,于2018年12月至2019年9月纳入1276名接受体外受精/卵胞浆内单精子注射治疗的女性。
  • 因多周期数量有限,仅分析其第一个体外受精/卵胞浆内单精子注射周期的结局。
  • 睡眠特征数据通过取卵日问卷收集,体外受精/卵胞浆内单精子注射结局从医疗记录中提取。
  • 采用准泊松、准二项或逻辑回归模型评估睡眠特征与生殖结局的关系,并调整相关混杂因素。
  • 按主观睡眠质量(好与差)和母亲年龄(≤30岁与>30岁)进行分层分析。

主要发现

  • 与每晚睡7至<8小时者相比,睡<7小时者获卵数减少11.5%(95%CI:-21.3%,-0.48%),成熟卵母细胞数减少11.9%(95%CI:-22.4%,-0.03%)。
  • 睡眠中点时间早于凌晨2:21(<2:21)或晚于凌晨3:00(≥3:00)以及主观睡眠质量差与受精率呈负相关。
  • 每周入睡困难超过3次者较无此困难者成熟卵母细胞数减少10.5%(95%CI:-18.6%,-1.6%),正常受精卵母细胞数减少14.8%(95%CI:-23.7%,-4.8%),优质胚胎数减少15.1%(95%CI:-25.4%,-3.5%)。
  • 每晚睡9至<10小时者较睡7至<8小时者临床妊娠几率更低(比值比=0.65,95%CI:0.44,0.98)。
  • 分层分析中,夜间睡眠时间与优质胚胎数和受精率的正相关仅存在于主观睡眠质量差的女性中(交互作用P值分别为0.02和0.03);夜间睡眠时间与着床或临床妊娠的正相关仅存在于30岁以上女性中(交互作用P值分别为0.04和0.01)。

临床怎么用

  • 作者认为不健康睡眠特征可能损害卵母细胞数量及其成熟或受精潜能。
  • 作者认为长夜间睡眠可能降低不孕女性临床妊娠几率,尤其是30岁以下女性。
  • 作者认为延长夜间睡眠时间可能是改善30岁以上女性和主观睡眠质量差女性体外受精/卵胞浆内单精子注射结局的潜在有益行为,尚需进一步研究。

局限性

  • 睡眠特征为自我报告,可能导致错分。
  • 睡眠中点时间作为时型的替代指标,可能发生非差异性错分,导致对相关关联的低估。
  • 在取卵日测量睡眠特征可能导致偏倚。
  • 由于夜间睡眠<7小时或≥10小时女性数量有限以及多重检验,不能排除偶然发现。
  • 结果可能受其他混杂因素影响,且可能不适用于其他种族女性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are sleep characteristics associated with outcomes of IVF/ICSI treatment? SUMMARY ANSWER: Nocturnal sleep <7 h/night and disturbed sleep are related to impaired oocyte and embryo yield, while longer nocturnal sleep might reduce the chance of a successful pregnancy, and the associations between nocturnal sleep duration and IVF/ICSI outcomes are modified by maternal age and subjective sleep quality. WHAT IS KNOWN ALREADY: Disturbed sleep and circadian rhythm contribute to impaired fecundity in the general population, but the effects of sleep characteristics on IVF/ICSI outcomes are largely unknown. STUDY DESIGN, SIZE, DURATION: This study was conducted among 1276 women undergoing IVF/ICSI treatment between December 2018 and September 2019 based on the Tongji Reproductive and Environmental cohort. Owing to the limited number of multiple cycles, we included only the outcomes of their first IVF/ICSI cycle in the current analysis. PARTICIPANTS/MATERIALS, SETTING, METHODS: Data on sleep characteristics were collected via questionnaires on the day of oocyte retrieval. IVF/ICSI outcomes were abstracted from medical records. Quasi-Poisson, quasi-binomial or logistic regression models were used to assess the relations between sleep characteristics and reproductive outcomes after adjusting for relevant confounders. We also performed stratified analyses by subjective sleep quality (good versus poor) and maternal age (≤30 versus >30 years). MAIN RESULTS AND THE ROLE OF CHANCE: Compared with women who slept 7 to <8 h/night, those who slept <7 h/night exhibited decreases in the number of retrieved and mature oocytes of 11.5% (95% CI: -21.3%, -0.48%) and 11.9% (95% CI: -22.4%, -0.03%), respectively. A mid-sleep time (MST) earlier than 2:21 a.m. (<2:21 a.m.) or later than 3:00 a.m. (≥3:00 a.m.) and poor subjective sleep quality were inversely associated with the fertilization rate. Women who had trouble falling asleep more than three times per week had a lower number of mature oocytes (-10.5%, 95% CI: -18.6%, -1.6%), normal fertilized oocytes (-14.8%, 95% CI: -23.7%, -4.8%) and good-quality embryos (-15.1%, 95% CI: -25.4%, -3.5%) than those who had no such trouble. In addition, women who slept 9 to <10 h/night had a lower chance of clinical pregnancy compared to women who slept 7 to <8 h/night (odds ratio = 0.65, 95% CI: 0.44, 0.98). In the stratified analyses, the positive associations of nocturnal sleep duration with the number of good-quality embryos and fertilization rate existed only among the women with poor subjective sleep quality (P for interaction = 0.02 and 0.03, respectively). Additionally, we found that the positive associations of nocturnal sleep duration with implantation or clinical pregnancy only existed among women aged over 30 years (P for interaction = 0.04 and 0.01, respectively). LIMITATIONS, REASONS FOR CAUTION: Sleep characteristics are self-reported, which may lead to misclassification. MST serves as a proxy of chronotype and may be non-differentially misclassified resulting in an underestimate of the association of interest. Measuring sleep characteristics on the day of oocyte retrieval may lead to bias. Chance findings cannot be excluded because of the limited number of women with <7 h or ≥10 h nocturnal sleep and multiple testing. Our results may be biased by other confounders and may not be generalizable to women of other ethnicities. WIDER IMPLICATIONS OF THE FINDINGS: Unhealthy sleep characteristics, including short nocturnal sleep, inappropriate sleep time, poor subjective sleep quality and having trouble falling asleep, may impair oocyte quantity and its potential to mature or be fertilized. Long nocturnal sleep might reduce the chance of clinical pregnancy among infertile females, especially women younger than 30 years old. Prolonged nocturnal sleep duration may be a potential beneficial behavior for improving IVF/ICSI outcomes for women aged over 30 years and women with poor subjective sleep quality, which requires further investigation. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China (81771654) and the National Key R&D Program of China (No. 2018YFC1004201). There are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Yao QY, Yuan XQ, Liu C, et al. Associations of sleep characteristics with outcomes of IVF/ICSI treatment: a prospective cohort study. Hum Reprod. 2022. PMID: 35259255. doi:10.1093/humrep/deac040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。